Mark Calmiano

Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors

Melissa L. Boby, D. Fearon, Matteo P. Ferla et al. · Science · 2023 · 158 citations · Full text

Discovery of a novel series of quinoxalines as inhibitors of c-Met kinase

John Porter, Simon Lumb, Fabien Lecomte et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 50 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, C-met Kinase +11

A white-knuckle ride of open COVID drug discovery

F. von Delft, Mark Calmiano, John D. Chodera et al. · Nature · 2021 · 44 citations · Full text

Virus Epidemiology, Medicine, Emerging Infectious Disease +4

Discovery of 4-azaindoles as novel inhibitors of c-Met kinase

John Porter, Simon Lumb, Richard J. Franklin et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 38 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, C-met Kinase +4

Turning high-throughput structural biology into predictive inhibitor design

Kadi L. Saar, William McCorkindale, D. Fearon et al. · Proceedings of the National Academy of Sciences · 2023 · 22 citations · Full text